The event will take place on November 3, 2025 beginning at 10 am ET and will feature presentations by ProQR Management and ...

Researchers at the Centre for Genomic Regulation show that cancer doesn’t invent new tricks—it reawakens embryonic splicing ...

ProQR ( ($PRQR) ) has shared an announcement. On October 20, 2025, ProQR Therapeutics announced that it received Clinical Trial Application (CTA) ...

Scientists have made a major discovery about ADAR1—a protein that controls RNA-induced immune responses—paving the way for better treatments for autoimmune diseases and cancer immunotherapy. ADAR1 ...

As CRISPR continues to drive breakthroughs in medicine, agriculture, and synthetic biology, understanding its origins does more than tell an ancient story. It provides a blueprint for engineering the ...

Chardan’s 9th Annual Genetic Medicines Conference – October 21, 2025 Company management will participate in an RNA Editing panel at 1:00 p.m. ET and will conduct 1x1 investor meetings in conjunction ...

A research team led by Rice's Yang Gao has uncovered new insights into the molecular mechanisms of ADAR1. ADAR1 converts adenosine to inosine in double-stranded RNA, a process essential for preventing ...

MIT researchers have dramatically lowered the error rate of prime editing, a technique with promise for treating numerous ...